TPO and cancer: Remarkably, autoimmune thyroiditis and appearance of autoantibodies including anti-thyroperoxidase and anti-thyroglobulin are frequently seen in cancer patients treated with checkpoint inhibitors, particularly with anti-PD1 antibody [31, 32].